CorVad Percutaneous Ventricular Assist System Study

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

October 18, 2024

Study Completion Date

October 18, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

CorVad Percutaneous Ventricular Assist System

The CorVad Percutaneous Ventricular Assist System provides hemodynamics support for intraoperative protection during high-risk percutaneous coronary intervention.

Trial Locations (12)

100037

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

130033

RECRUITING

China-Japan Union Hospital of Jilin University, Changchun

150001

NOT_YET_RECRUITING

The First Affiliated Hospital of Harbin Medical University, Harbin

150081

NOT_YET_RECRUITING

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

200120

RECRUITING

Shanghai East Hospital of Tongji University, Shanghai

310003

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

350001

NOT_YET_RECRUITING

Fujian Medical University Union Hospital, Fuzhou

410002

RECRUITING

Hunan Provincial People's Hospital, Changsha

510080

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

710032

NOT_YET_RECRUITING

Tangdu Hospital of Air Force Medical University, Xi'an

NOT_YET_RECRUITING

Xijing Hospital of Air Force Military Medical University, Xi’an

730000

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

All Listed Sponsors
lead

Shenzhen Core Medical Technology CO.,LTD.

INDUSTRY